Analyst consensus rating
Q32 Bio Analyst Rating: Strong Buy
Direct answer
Q32 Bio's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $41.00.
Forecast evidence checked September 6, 2026.
Get free Q32 Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $11.99
- Average price target
- $41.00
- High price target
- $59.00
- Low price target
- $34.00
- Low target gap
- +183.6%
- Target upside
- +242%
- High target gap
- +392.1%
- Target range width
- 208.5%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- September 6, 2026
- Valid through
- September 13, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Q32 Bio?
Q32 Bio has a verified Strong Buy consensus. The same dataset has an average price target of $41.00.
How far are Q32 Bio's low and high targets from the recorded price?
The low target implies +183.6%, while the high target implies +392.1%.
How many analysts are included in Q32 Bio's consensus?
The verified consensus includes 5 analysts.
How is Q32 Bio's target upside or downside calculated?
The average target of $41.00 is divided by the recorded price of $11.99, then one is subtracted to produce +242%. This does not guarantee a future return.
When was Q32 Bio's analyst forecast verified?
The data was verified on 2026-09-06. The dataset is valid through 2026-09-13.